Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract
Clinical trial NCT04617756 · RECRUITING
Trial details
- NCT number
- NCT04617756
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-29
- Primary completion
- 2025-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.